Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
17.87
-0.53 (-2.88%)
At close: Dec 20, 2024, 4:00 PM
17.99
+0.12 (0.67%)
After-hours: Dec 20, 2024, 7:46 PM EST

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
13,1781,829897263387537
Upgrade
Market Cap Growth
1151.11%103.94%241.23%-32.01%-28.06%152.03%
Upgrade
Enterprise Value
12,7241,737779184366521
Upgrade
Last Close Price
17.872.614.252.694.701.60
Upgrade
PS Ratio
--1272.24145.30449.56663.04
Upgrade
PB Ratio
30.0823.547.083.164.876.81
Upgrade
P/TBV Ratio
37.4524.137.183.715.878.43
Upgrade
EV/Sales Ratio
--1105.42101.96425.47642.56
Upgrade
Debt / Equity Ratio
0.071.374.100.030.010.01
Upgrade
Asset Turnover
--0.000.020.01-
Upgrade
Quick Ratio
8.269.179.153.473.855.05
Upgrade
Current Ratio
8.319.3016.933.804.415.78
Upgrade
Return on Equity (ROE)
-73.21%-601.85%-75.05%-108.89%-66.57%-
Upgrade
Return on Assets (ROA)
-31.47%-12.79%-10.43%-49.91%-32.92%-
Upgrade
Return on Capital (ROIC)
-33.55%-13.38%-11.09%-64.91%-40.97%-
Upgrade
Earnings Yield
-1.49%-33.62%-8.78%-33.71%-13.63%-5.91%
Upgrade
FCF Yield
-0.86%-4.20%-4.71%-27.73%-12.55%-4.26%
Upgrade
Buyback Yield / Dilution
-28.70%-220.50%-109.60%-32.67%-111.78%-90.55%
Upgrade
Total Shareholder Return
-28.70%-220.50%-109.60%-32.67%-111.78%-90.55%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.